In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits

Molecular Pharmaceutics

Volumn 3, Issue 4, 2006, Pages 431-440

  Anand, Banmeet S ^a   Katragadda, Suresh ^a   Gunda, Sriram ^a   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Acyclovir; Dipeptide prodrugs; Microdialysis; Ocular absorption

Indexed keywords

ACICLOVIR; ACICLOVIR DERIVATIVE; ACYCLOVIR DIPEPTIDE ESTER; DIPEPTIDE DERIVATIVE; GLYCINE; PRODRUG; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORNEA; DRUG ABSORPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ABSORPTION; ACYCLOVIR; ANIMALS; AQUEOUS HUMOR; CORNEA; MALE; MICRODIALYSIS; OPHTHALMIC SOLUTIONS; PRODRUGS; RABBITS; VALINE;

EID: 33748468344     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp0498998     Document Type: Article

References (30)

1. Turner, J.; Turner, O. C.; Baird, N.; Orme, I. M.; Wilcox, C. L.; Baldwin, S. L., Influence of increased age on the development of herpes stromal keratitis. Exp. Gerontol. 2003, 38 (10), 1205-12.
2. Infectious Diseases: Antiviral Drugs. The Merck Manual of Diagnosis and Therapy, 17th ed.; Merck Research Laboratories, Division of Merck & Co., Inc.; John Wiley & Sons: New York, 1999.
3. Hughes, P. M.; Mitra, A. K. Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2′-esters in rabbit epithelial keratitis. J. Ocul. Pharmacol. 1993, 9 (4), 299-309.
4. Stella, V. J.; Charman, W. N.; Naringrekar, V. H. Prodrugs. Do they have advantages in clinical practice? Drugs 1985, 29 (5), 455-73.
5. Dey, S.; Anand, B. S.; Patel, J.; Mitra, A. K. Transporters/receptors in the anterior chamber: pathways to explore ocular drug delivery strategies. Expert Opin. Biol. Ther. 2003, 3 (1), 23-44.
6. Dantzig, A. H.; Bergin, L. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta 1990, 1027 (3), 211-7.
7. Hashimoto, N.; Fujioka, T.; Toyoda, T.; Muranushi, N.; Hirano, K. Renin inhibitor: transport mechanism in rat small intestinal brush-border membrane vesicles. Pharm. Res. 1994, 11 (10), 1448-51.
8. Kiss, A.; Farah, K.; Kim, J.; Garriock, R. J.; Drysdale, T. A.; Hammond, J. R. Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochem. J. 2000, 352 (Part 2), 363-72.
9. Han, H.; de Vrueh, R. L.; Rhie, J. K.; Covitz, K. M.; Smith, P. L.; Lee, C. P.; Oh, D. M.; Sadee, W.; Amidon, G. L. 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm. Res. 1998, 15 (8), 1154-9.
10. Inui, K.; Yamamoto, M.; Saito, H. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes. J. Pharmacol. Exp. Ther. 1992, 261 (1), 195-201.
11. Temple, C. S.; Stewart, A. K.; Meredith, D.; Lister, N. A.; Morgan, K. M.; Collier, I. D.; Vaughan-Jones, R. D.; Boyd, C. A.; Bailey, P. D.; Bronk, J. R. Peptide mimics as substrates for the intestinal peptide transporter. J. Biol. Chem. 1998, 273 (1), 20-2.
12. Doring, F.; Will, J.; Amasheh, S.; Clauss, W.; Ahlbrecht, H.; Daniel, H. Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter. J. Biol. Chem. 1998, 273 (36), 23211-8.
13. Steingrimsdottir, H.; Gruber, A.; Palm, C.; Grimfors, G.; Kalin, M.; Eksborg, S. Bioavailability of aciclovir after oral administration of aciclovir and its prodrug valaciclovir to patients with leukopenia after chemotherapy. Antimicrob. Agents Chemother. 2000, 44 (1), 207-9.
14. Han, H. K.; Oh, D. M.; Amidon, G. L. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter. Pharm. Res. 1998, 15 (9), 1382-6.
15. Anand, B. S.; Mitra, A. K. Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea. Pharm. Res. 2002, 19 (8), 1194-202.
16. Anand, B.; Nashed, Y.; Mitra, A. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea. Curr. Eve Res. 2003, 26(3-4), 151-63.
17. Anand, B. S.; Hill, J. M.; Dey, S.; Maruyama, K.; Bhattacharjee, P. S.; Myles, M. E.; Nashed, Y. E.; Mitra, A. K. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model. Invest. Ophthalmol. Visual Sci. 2003, 44 (6), 2529-34.
18. Lee, V. H.; Robinson, J. R. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J. Pharm. Sci. 1979, 68 (6), 673-84.
19. Makoid, M. C.; Robinson, J. R. Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye. J. Pharm. Sci. 1979, 68 (4), 435-43.
20. Miller, S. C.; Himmelstein, K. J.; Patton, T. F. A physiologically based pharmacokinetic model for the intraocular distribution of pilocarpine in rabbits. J. Pharmacokinet. Biopharm. 1981, 9 (6), 653-77.
21. Eller, M. G.; Schoenwald, R. D.; Dixson, J. A.; Segarra, T.; Barfknecht, C. F. Topical carbonic anhydrase inhibitors IV: Relationship between excised corneal permeability and pharmacokinetic factors. J. Pharm. Sci. 1985, 74 (5), 525-9.
22. Rittenhouse, K. D.; Pollack, G. M. Microdialysis and drug delivery to the eye. Adv. Drug Delivery Rev. 2000, 45 (2-3), 229-41.
23. Waga, J.; Ohta, A.; Ehinger, B. Intraocular microdialysis with permanently implanted probes in rabbit. Acta Ophthalmol. 1991, 69 (5), 618-24.
24. Waga, J.; Nilsson-Ehle, I.; Ljungberg, B.; Skarin, A.; Stahle, L.; Ehinger, B. Microdialysis for pharmacokinetic studies of ceftazidime in rabbit vitreous. J. Ocul. Pharmacol. Ther. 1999, 15 (5), 455-63.
25. Stempels, N.; Tassignon, M. J.; Sarre, S. A removable ocular microdialysis system for measuring vitreous biogenic amines. Graefe's Arch. Clin. Exp. Ophthalmol. 1993, 231 (11), 651-5.
26. Macha, S.; Mitra, A. K. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique. Exp. Eye Res. 2001, 72 (3), 289-99.
27. Anand, B. S.; Patel, J.; Mitra, A. K. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2. J. Pharmacol. Exp. Ther. 2003, 304 (2), 781-91.
28. Stratford, R. E., Jr.; Lee, V. H. Ocular aminopeptidase activity and distribution in the albino rabbit. Curr. Eye Res. 1985, 4 (9). 995-9.
29. Rose, G. D.; Geselowitz, A. R.; Lesser, G. J.; Lee, R. H.; Zehfus. M. H. Hydrophobicity of amino acid residues in globular proteins. Science 1985, 229 (4716), 834-8.
30. Anand, B. S.; Katragadda, S.; Nashed, Y. E.; Mitra, A. K. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium. Curr. Eye Res. 2004, 29(2-3), 153-66.